Cargando…

Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)

One of the most challenging problems in the treatment of glioblastoma (GBM) is the highly infiltrative nature of the disease. Infiltrating cells that are non-resectable are left behind after debulking surgeries and become a source of regrowth and recurrence. To prevent tumor recurrence and increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasilev, Alex, Sofi, Roba, Smith, Stuart J., Rahman, Ruman, Teschemacher, Anja G., Kasparov, Sergey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533469/
https://www.ncbi.nlm.nih.gov/pubmed/34680569
http://dx.doi.org/10.3390/biomedicines9101453
_version_ 1784587320337367040
author Vasilev, Alex
Sofi, Roba
Smith, Stuart J.
Rahman, Ruman
Teschemacher, Anja G.
Kasparov, Sergey
author_facet Vasilev, Alex
Sofi, Roba
Smith, Stuart J.
Rahman, Ruman
Teschemacher, Anja G.
Kasparov, Sergey
author_sort Vasilev, Alex
collection PubMed
description One of the most challenging problems in the treatment of glioblastoma (GBM) is the highly infiltrative nature of the disease. Infiltrating cells that are non-resectable are left behind after debulking surgeries and become a source of regrowth and recurrence. To prevent tumor recurrence and increase patient survival, it is necessary to cleanse the adjacent tissue from GBM infiltrates. This requires an innovative local approach. One such approach is that of photodynamic therapy (PDT) which uses specific light-sensitizing agents called photosensitizers. Here, we show that tetramethylrhodamine methyl ester (TMRM), which has been used to asses mitochondrial potential, can be used as a photosensitizer to target GBM cells. Primary patient-derived GBM cell lines were used, including those specifically isolated from the infiltrative edge. PDT with TMRM using low-intensity green light induced mitochondrial damage, an irreversible drop in mitochondrial membrane potential and led to GBM cell death. Moreover, delayed photoactivation after TMRM loading selectively killed GBM cells but not cultured rat astrocytes. The efficacy of TMRM-PDT in certain GBM cell lines may be potentiated by adenylate cyclase activator NKH477. Together, these findings identify TMRM as a prototypical mitochondrially targeted photosensitizer with beneficial features which may be suitable for preclinical and clinical translation.
format Online
Article
Text
id pubmed-8533469
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85334692021-10-23 Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM) Vasilev, Alex Sofi, Roba Smith, Stuart J. Rahman, Ruman Teschemacher, Anja G. Kasparov, Sergey Biomedicines Article One of the most challenging problems in the treatment of glioblastoma (GBM) is the highly infiltrative nature of the disease. Infiltrating cells that are non-resectable are left behind after debulking surgeries and become a source of regrowth and recurrence. To prevent tumor recurrence and increase patient survival, it is necessary to cleanse the adjacent tissue from GBM infiltrates. This requires an innovative local approach. One such approach is that of photodynamic therapy (PDT) which uses specific light-sensitizing agents called photosensitizers. Here, we show that tetramethylrhodamine methyl ester (TMRM), which has been used to asses mitochondrial potential, can be used as a photosensitizer to target GBM cells. Primary patient-derived GBM cell lines were used, including those specifically isolated from the infiltrative edge. PDT with TMRM using low-intensity green light induced mitochondrial damage, an irreversible drop in mitochondrial membrane potential and led to GBM cell death. Moreover, delayed photoactivation after TMRM loading selectively killed GBM cells but not cultured rat astrocytes. The efficacy of TMRM-PDT in certain GBM cell lines may be potentiated by adenylate cyclase activator NKH477. Together, these findings identify TMRM as a prototypical mitochondrially targeted photosensitizer with beneficial features which may be suitable for preclinical and clinical translation. MDPI 2021-10-13 /pmc/articles/PMC8533469/ /pubmed/34680569 http://dx.doi.org/10.3390/biomedicines9101453 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vasilev, Alex
Sofi, Roba
Smith, Stuart J.
Rahman, Ruman
Teschemacher, Anja G.
Kasparov, Sergey
Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)
title Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)
title_full Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)
title_fullStr Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)
title_full_unstemmed Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)
title_short Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)
title_sort feasibility of photodynamic therapy for glioblastoma with the mitochondria-targeted photosensitizer tetramethylrhodamine methyl ester (tmrm)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533469/
https://www.ncbi.nlm.nih.gov/pubmed/34680569
http://dx.doi.org/10.3390/biomedicines9101453
work_keys_str_mv AT vasilevalex feasibilityofphotodynamictherapyforglioblastomawiththemitochondriatargetedphotosensitizertetramethylrhodaminemethylestertmrm
AT sofiroba feasibilityofphotodynamictherapyforglioblastomawiththemitochondriatargetedphotosensitizertetramethylrhodaminemethylestertmrm
AT smithstuartj feasibilityofphotodynamictherapyforglioblastomawiththemitochondriatargetedphotosensitizertetramethylrhodaminemethylestertmrm
AT rahmanruman feasibilityofphotodynamictherapyforglioblastomawiththemitochondriatargetedphotosensitizertetramethylrhodaminemethylestertmrm
AT teschemacheranjag feasibilityofphotodynamictherapyforglioblastomawiththemitochondriatargetedphotosensitizertetramethylrhodaminemethylestertmrm
AT kasparovsergey feasibilityofphotodynamictherapyforglioblastomawiththemitochondriatargetedphotosensitizertetramethylrhodaminemethylestertmrm